Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose salicylate on platelet function in renal failure patients treated with darbepoetin alfa (EPOASA)
2018-002318-11Phase 4Terminated
- Sponsor
- Zealand University Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in chronic kidney disease (CKD) and uremia, sponsored by Zealand University Hospital. Primary endpoint: Platelet function evaluation at end of each therapeutic interval. Started Jan 2020; status: terminated.
02
Drugs
aspirin
03
Conditions
chronic kidney disease (CKD)uremia
Beyond the preview
Go deeper on 2018-002318-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002318-11.